154 results on '"Shields, Adrian"'
Search Results
2. Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients
3. Paracetamol suppresses neutrophilic oxygen radicals through competitive inhibition and scavenging
4. Comparison of short- and long-term humoral immune responses to pneumococcal polysaccharide and glycoconjugate vaccines in an HIV-infected population
5. Early neutrophil trajectory following clozapine may predict clozapine response – Results from an observational study using electronic health records
6. WCOs - slipping through the cracks
7. Sustainability : the Gordian Knot
8. Meat in the middle
9. Which agenda was that?
10. Subdivisions and oceans
11. The American way
12. Property transfer and LATE's
13. New role for the G-G
14. Deforestation
15. Mixed objectives
16. Coastal policy : vision and revision
17. Saliva antiviral antibody levels are detectable but correlate poorly with serum antibody levels following SARS-CoV-2 infection and/or vaccination
18. SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study
19. Health Care Utilisation in a Cohort of Patients with Primary and Secondary Antibody Deficiency in the United Kingdom.
20. Resolution of Persistent COVID-19 After Convalescent Plasma in a Patient with B Cell Aplasia
21. Safety and 30-day outcomes of tracheostomy for COVID-19: a prospective observational cohort study
22. Sensitive Detection of SARS-CoV-2-Specific Antibodies in Dried Blood Spot Samples
23. A Novel, Heterozygous Three Base-Pair Deletion in CARD11 Results in B Cell Expansion with NF-κB and T Cell Anergy Disease
24. The primary immunodeficiency disorders
25. Changes in immunoglobulin levels during clozapine treatment in schizophrenia
26. Correction to: Resolution of Persistent COVID-19 After Convalescent Plasma in a Patient with B Cell Aplasia
27. Dose reductions in immunoglobulin replacement are associated with increased antibiotic usage in patients with antibody deficiency.
28. SARS-CoV-2 infection is associated with anti-desmoglein 2 autoantibody detection.
29. Clinical and laboratory characteristics of patients with symptomatic secondary immunodeficiency following the treatment of haematological malignancies.
30. SARS‐CoV‐2‐specific IgG1/IgG3 but not IgM in children with Pediatric Inflammatory Multi‐System Syndrome
31. Implications of suboptimal measles immunity in UK health-care workers
32. Correlation Between Postvaccination Anti-Spike Antibody Titers and Protection Against Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Population-Based Longitudinal Study.
33. A twist in the tale: epiploic appendagitis mimicking acute appendicitis
34. Strongyloides stercoralis hyperinfection presenting as subacute small bowel obstruction following immunosuppressive chemotherapy for multiple myeloma
35. Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience.
36. Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK.
37. Health Care Utilisation in a Cohort of Patients with Primary and Secondary Antibody Deficiency in the United Kingdom
38. SARS-CoV-2 Spike- and Nucleoprotein-Specific Antibodies Induced After Vaccination or Infection Promote Classical Complement Activation.
39. Increased Seroprevalence and Improved Antibody Responses Following Third Primary SARS-CoV-2 Immunisation: An Update From the COV-AD Study.
40. Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals.
41. Pro-resolution immunological networks: binding immunoglobulin protein and other resolution-associated molecular patterns
42. SARS-CoV-2 vaccine responses following CD20-depletion treatment in patients with haematological and rheumatological disease: a West Midlands Research Consortium study.
43. Classical and Non-classical Presentations of Complement Factor I Deficiency: Two Contrasting Cases Diagnosed via Genetic and Genomic Methods
44. Development of a high‐sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS‐CoV‐2 spike glycoprotein in serum and saliva.
45. Establishing the prevalence of common tissue‐specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection.
46. Early observations on the impact of a healthcare worker COVID-19 vaccination programme at a major UK tertiary centre.
47. T cell response to SARS-CoV-2 infection in humans: A systematic review.
48. Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response.
49. Antibody response to SARS-CoV-2 infection in humans: A systematic review.
50. SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.